We are live on ! Find out more
REVH

Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock

Delisted

REVH was delisted on the 6th of December, 2022.

68 hedge funds and large institutions have $471M invested in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 10

0% more funds holding

Funds holding: 6868 (0)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

1% less capital invested

Capital invested by funds: $477M → $471M (-$5.36M)

Holders
68
Holders Change
Holders Change %
0%
% of All Funds
1.17%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
6
Increased
18
Reduced
10
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$475K +$569K +58,023 New
Goldman Sachs
52
Goldman Sachs
New York
$450K
HF
53
HRT Financial
New York
$422K +$314 +32 +0.1%
RCM
54
Robinson Capital Management
Michigan
$372K +$108K +11,000 +41%
Susquehanna International Group
55
Susquehanna International Group
Pennsylvania
$312K +$171K +17,415 +122%
DAM
56
DLD Asset Management
New York
$309K
Geode Capital Management
57
Geode Capital Management
Massachusetts
$299K
VF
58
Virtu Financial
New York
$294K +$294K +29,919 New
TI
59
Tidal Investments
Wisconsin
$264K
SSA
60
Schonfeld Strategic Advisors
New York
$169K
GCL
61
Glazer Capital LLC
New York
$120K +$119K +12,173 New
Calamos Advisors
62
Calamos Advisors
Illinois
$98K +$98.1K +10,000 New
PCM
63
PenderFund Capital Management
British Columbia, Canada
$96K +$5.79K +590 +9%
EC
64
Elequin Capital
New York
$69K +$68.7K +7,000 New
LCM
65
Lynwood Capital Management
Ontario, Canada
$49K
UBS Group
66
UBS Group
Switzerland
$11K -$11.6K -1,179 -51%
First Manhattan
67
First Manhattan
New York
$4K
Bank of Montreal
68
Bank of Montreal
Ontario, Canada
$1.89K -$467K -47,560 -20%
Alyeska Investment Group
69
Alyeska Investment Group
Illinois
-$19.5M -2,000,000 Closed
BCM
70
Basso Capital Management
Connecticut
-$2.44M -250,050 Closed
Parallax Volatility Advisers
71
Parallax Volatility Advisers
California
-$1.71M -175,017 Closed
FLC
72
Fifth Lane Capital
Texas
-$244K -25,000 Closed
PCM
73
Penserra Capital Management
California
-$56K -5,829 Closed
CM
74
Cohanzick Management
New York
-$4K -400 Closed

REVH Hedge Fund Activity: Q3 2022 in Review

68 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) for Q3 2022, worth a combined $471M — down 1.1% from $477M a quarter earlier.

Fund positioning in REVH was balanced in Q3 2022: 6 funds opened new positions, 6 closed out, 18 added to existing stakes and 10 trimmed.

The largest buyer was Magnetar Financial, adding an estimated $14M. The largest seller was HGC Investment Management, cutting an estimated $28.3M.

  • 68 institutional investors held Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $471M of Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock stock for Q3 2022, down 1.1% quarter-over-quarter.
  • 6 funds opened new Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock positions in Q3 2022 and 6 closed out, a net change of 0 holders.
  • The largest Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock buyer in Q3 2022 was Magnetar Financial, an estimated $14M added.
  • The largest Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock seller in Q3 2022 was HGC Investment Management, an estimated $28.3M sold.

Based on aggregated 13F filings for Q3 2022.